Skip to content
Screener

Atara Biotherapeutics ATRA Q4 2025 Annual earnings

Reported March 16, 2026 · Before market open

Revenue$1.6MMiss by $1.7M
EPS-$0.25Miss by $0.16
Revenue estimate$3.4M
EPS estimate-$0.09

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$800.0K
EPS estimate-$0.13

FAQ

When did Atara Biotherapeutics report Q4 2025 earnings?
Atara Biotherapeutics (ATRA) reported Q4 2025 earnings on March 16, 2026 before market open.
What were Atara Biotherapeutics's Q4 2025 revenue and EPS?
Atara Biotherapeutics reported revenue of $1.6M and eps of $-0.25 for Q4 2025.
Did Atara Biotherapeutics beat estimates in Q4 2025?
Revenue missed the consensus estimate of $3.4M by $1.7M. EPS missed the consensus estimate of $-0.09 by $0.16.
How did Atara Biotherapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 95.0% from $32.8M a year earlier and eps grew 79.0% from $-1.19.
Where can I find Atara Biotherapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-108344) and the 10-K periodic report (0001193125-26-108361) directly on SEC EDGAR. The filing index links above go to sec.gov.